Andrew Hertler, MD

As the chief medical officer of New Century Health, Dr. Andrew Hertler is responsible for the advancement of the company's clinical quality and value-based strategy, utilization management policies and clinical thought leadership initiatives. A practicing board-certified oncologist for 30 years, he is a nationally recognized leader in oncology clinical practice. Dr. Hertler has volunteered on a number of American Society of Clinical Oncology (ASCO) committees, including the Clinical Practice, Quality of Care and Payment Reform Committees, as well as the Quality Oncology Practice Initiative Certification Program Oversight Council.

  • How Real-World Evidence Can Transform High-Value Oncology Pathways

    How Real-World Evidence Can Transform High-Value Oncology Pathways

    Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.

    Read Article
  • Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    Will COVID-19 Spark a Long-Needed Conversation Around Value in Oncology?

    The pandemic has forced difficult trade-offs between cancer treatment and infection prevention. We also need to be willing to make hard decisions around value, our CMO writes.

    Read Article
  • Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Cancer Care During COVID-19: How Practices and Health Plans Can Navigate New Risks

    Our CMO Dr. Andrew Hertler offers insights for minimizing patients' risk of COVID-19 when their cancer therapies cannot be delayed.

    Read Article
  • Creating a "Culture of Yes" in Prior Authorization

    Creating a "Culture of Yes" in Prior Authorization

    Prior authorization is a major source of frustration for providers and patients. Our CMO Dr. Andrew Hertler explains how a value-based approach can change that.

    Read Article
  • Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus

    Controlling Total Cost of Care in Oncology: Three Areas Where Health Plans Should Focus

    Our CMO Dr. Andrew Hertler outlines value-based payment strategies and tools to help oncologists improve care across the patient journey.

    Read Article
  • Putting the CAR-T Before the Horse? Understanding CMS’ Recent Cancer Therapy Decisions

    Putting the CAR-T Before the Horse? Understanding CMS’ Recent Cancer Therapy Decisions

    Dr. Hertler, CMO at New Century Health, shares his thoughts and perspectives on the future of CAR T-cell therapy and the recent CMS announcements.

    Read Article
  • Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology

    Using Big Data and Predictive Analytics to Determine Patient Risk in Oncology

    Dr. Hertler, Chief Medical Officer at New Century Health, and others describe the potential of big data and predictive analytics to improve clinical risk stratification for cancer patients.

    Read more
  • Cancer Care Costs Everyone Too Much. Here's How We Fix It.

    Cancer Care Costs Everyone Too Much. Here's How We Fix It.

    Dr. Andrew Hertler, Chief Medical Officer at New Century Health, demonstrates how clinical pathways improve patient outcomes while decreasing waste and cost.

    Read Article
  • loading
    Loading More...